+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Regenerative Medicines: Bone and Joint Applications

  • PDF Icon

    Report

  • 105 Pages
  • June 2022
  • Region: Global
  • BCC Research
  • ID: 5311353

The report explains critical trends in the regenerative medicine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.



This study looks at most of the systems affected by factors such as R&D spending and increasing competition and new technologies.

This report also covers merger and acquisition strategies and collaborations, as well as the strengths and weaknesses of each strategy type.

The market has also been analyzed based on regenerative medicine for bone and joint applications. Categories considered in this report include allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases and others.

The report provides information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Report Includes

  • 51 tables
  • An overview of the global market for regenerative medicines for bone and joint applications
  • Estimation of the market size and analyses of global market trends, with data from 2020 to 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
  • Characterization and quantification of market potential for regenerative medicines by technology, application, and region
  • Coverage and discussion on regulatory delays due to COVID-19, clinical trials and product launches of the industry
  • Description of principle approaches to regenerative medicine and discussion on importance of scaffolding in tissue engineering
  • Information on major drivers and regional dynamics of the market and current trends within the industry
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies
  • Company profiles of major players, including Anika Therapeutics, Conmed Corp., Johnson & Johnson and Stryker Corp.
Frequently Asked Questions about the Global Regenerative Medicines Market

What is the estimated value of the Global Regenerative Medicines Market?

The Global Regenerative Medicines Market was estimated to be valued at $9.4 Billion in 2022.

What is the growth rate of the Global Regenerative Medicines Market?

The growth rate of the Global Regenerative Medicines Market is 11.6%, with an estimated value of $16.4 Billion by 2027.

What is the forecasted size of the Global Regenerative Medicines Market?

The Global Regenerative Medicines Market is estimated to be worth $16.4 Billion by 2027.

Who are the key companies in the Global Regenerative Medicines Market?

Key companies in the Global Regenerative Medicines Market include Anika Therapeutics Inc., Arthrex Inc., Baxter International Inc., Bioventus, Conmed Corp., Depuy Synthes Products Inc. (Part of Johnson & Johnson), Medtronic plc, Seikagaku Corp. and Stryker Corp..

Table of Contents

Chapter 1 Introduction
  • Background
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • What's New in this Update?
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
  • Overview of Regenerative Medicine
  • How Regenerative Medicine Works
  • Principal Approaches to Regenerative Medicine
  • Cells and Tissues
  • Tissue Engineering
  • Importance of Scaffolding in Tissue Engineering
  • Plastic Scaffolding
  • Blood Vessel Scaffolding
  • Center for Integration of Medicine and Innovative Technology (Cimit)
  • Embryonic Stem Cells
Chapter 4 Impact of Covid-19
  • Overview
  • Impact of Covid-19 on Cell and Gene Therapies, and Regenerative Medicine for Bone and Joint Applications
  • Direct Impact on Clinical Trials in Cell and Gene Therapy
Chapter 5 Market Dynamics
  • Market Drivers
  • Rising Number of Bone and Joint Disorders and Orthopedic Surgeries
  • Increasing Product Approvals and Launches
  • R&D for Stem and Gene Therapies
  • Market Restraints
  • Stringent Government Regulatory Settings in R&D
  • Market Opportunities
  • Growing Pipeline for Regenerative Medicines
  • Competitive Landscape
Chapter 6 Market Breakdown by Technology
  • Global Market by Technology
  • Biomaterials
  • Biomaterials for Regeneration
  • Market Size and Forecast
  • Stem Cell Therapy
  • Market Size and Forecast
  • Tissue Engineering
  • Market Size and Forecast
Chapter 7 Market Breakdown by Application
  • Global Market by Application
  • Allogeneic Bones
  • Market Size and Forecast
  • Autogenic Bones
  • Market Size and Forecast
  • Bone Graft Substitutes
  • Market Size and Forecast
  • Osteoarticular Diseases
  • Market Size and Forecast
  • Other Diseases
  • Market Size and Forecast
Chapter 8 Market Breakdown by Region
  • Global Market by Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Australia
  • India
  • Rest of Asia-Pacific
  • Rest of the World
Chapter 9 Company Profiles
  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • Baxter International Inc.
  • Bioventus
  • Conmed Corp.
  • Depuy Synthes Products Inc. (Part of Johnson & Johnson)
  • Medtronic plc
  • Seikagaku Corp.
  • Smith & Nephew plc
  • Stryker Corp.
  • Zimmer Biomet Holdings Inc.
Chapter 10 Appendix: List of Acronyms
List of Tables
Summary Table: Global Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table A: Comparison of Changes in the Segmentation of Previous and Current Version of Report
Table 1: Top Three Companies in the Global Market for Regenerative Medicine for Bone and Joint Applications, 2021
Table 2: Global Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 3: Biomaterial-Assisted Gene Therapy in Musculoskeletal Research
Table 4: Global Market for Biomaterials in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 5: Global Market for Stem Cell Therapy in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 6: Biomaterials Utilized for Specific Target Tissues and Cell Types
Table 7: Global Market for Tissue Engineering in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 8: Global Market for Regenerative Medicine for Bone and Joint Applications, by Application, Through 2027
Table 9: Global Market for Allogeneic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 10: Global Market for Autogenic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 11: Global Market for Bone Graft Substitutes in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 12: Global Market for Osteoarticular Diseases in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 13: Global Market for Other Disease Applications in Regenerative Medicine for Bone and Joint Applications, by Region, Through 2027
Table 14: Global Regenerative Medicine Market for Bone and Joint Applications, by Region, Through 2027
Table 15: North American Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 16: North American Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 17: European Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 18: European Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 19: Asia-Pacific Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 20: Asia-Pacific Market for Regenerative Medicine for Bone and Joint Applications, by Country, Through 2027
Table 21: Rest of the World Market for Regenerative Medicine for Bone and Joint Applications, by Technology, Through 2027
Table 22: Anika Therapeutics: R&D Expenditures, 2019-2021
Table 23: Anika Therapeutics: Products Offered
Table 24: Anika Therapeutics: Recent Developments
Table 25: Arthrex Inc.: Products Offered
Table 26: Arthrex Inc.: Recent Developments
Table 27: Baxter International: Products Offered
Table 28: Bioventus: Products Offered
Table 29: Bioventus: Recent Developments
Table 30: Conmed Corp.: R&D Expenditures, 2019-2021
Table 31: Conmed Corp.: Products Offered
Table 32: Conmed Corp.: Recent Developments
Table 33: Johnson & Johnson (DePuy Synthes Companies): R&D Expenditures, 2019-2021
Table 34: Johnson & Johnson (DePuy Synthes Companies): Products Offered
Table 35: Johnson & Johnson (DePuy Synthes Companies): Recent Developments
Table 36: Medtronic PLC: R&D Expenditures, 2019-2021
Table 37: Medtronic PLC: Products Offered
Table 38: Medtronic PLC: Recent Developments
Table 39: Seikagaku Corp.: Products Offered
Table 40: Seikagaku Corp.: Recent Developments
Table 41: Smith & Nephew: R&D Expenditures, 2019-2021
Table 42: Smith & Nephew: Products Offered
Table 43: Smith & Nephew: Recent Developments
Table 44: Stryker Corp.: R&D Expenditures, 2019-2021
Table 45: Stryker Corp.: Products Offered
Table 46: Stryker Corp.: Recent Developments
Table 47: Zimmer Biomet Holdings: R&D Expenditures, 2018-2020
Table 48: Zimmer Biomet Holdings: Products Offered
Table 49: Zimmer Biomet Holdings: Recent Developments
Table 50: Acronyms Used in This Report
List of Figures
Summary Figure: Global Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 1: Global Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 2: Global Market for Regenerative Medicine for Biomaterials in the Bone and Joint Applications, 2020-2027
Figure 3: Global Market for Biomaterials in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 4: Global Market for Stem Cell Therapy in Bone and Joint Applications, 2020-2027
Figure 5: Global Market for Stem Cell Therapy in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 6: Global Market for for Tissue Engineering in Bone and Joint Applications, 2020-2027
Figure 7: Global Market for Tissue Engineering in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 8: Global Market Shares of Regenerative Medicine in Bone and Joint Applications, by Application, 2021
Figure 9: Global Market for Allogeneic Bones in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 10: Global Market for Allogeneic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 11: Global Market for Autogenic Bones in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 12: Global Market for Autogenic Bones in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 13: Global Market for Bone Graft Substitutes in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 14: Global Market for Bone Graft Substitutes in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 15: Global Market for Osteoarticular Diseases in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 16: Global Market for Osteoarticular Diseases in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 17: Global Market for Other Applications in Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 18: Global Market for Other Disease Applications in Regenerative Medicine for Bone and Joint Applications, by Region, 2020-2027
Figure 19: Global Regenerative Medicine Market for Bone and Joint Applications, by Region, 2020-2027
Figure 20: Global Market Shares of Regenerative Medicine for Bone and Joint Applications, by Region, 2021
Figure 21: North American Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 22: North American Market Shares of for Regenerative Medicine for Bone and Joint Applications, by Country, 2020
Figure 23: U.S. Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 24: Canadian Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 25: European Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 26: European Market Shares of Regenerative Medicine for Bone and Joint Applications, by Country, 2021
Figure 27: German Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 28: French Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 29: U.K. Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 30: Italian Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 31: Spanish Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 32: Rest of Europe Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 33: Asia-Pacific Market Shares of Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 34: Asia-Pacific Market Shares of Regenerative Medicine for Bone and Joint Applications, by Country, 2021
Figure 35: Chinese Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 36: Japanese Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 37: Australian Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 38: Indian Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 39: Rest of Asia-Pacific Market for Regenerative Medicine for Bone and Joint Applications, 2020-2027
Figure 40: Rest of the World Market for Regenerative Medicine for Bone and Joint Applications, by Technology, 2021
Figure 41: Anika Therapeutics: Net Revenue, 2017-2021
Figure 42: Anika Therapeutics: Revenue Share, by Business Segment, 2020
Figure 43: Anika Therapeutics: Revenue Share, by Region/Country, 2021
Figure 44: Baxter International: Net Revenue, 2017-2021
Figure 45: Baxter International: Revenue Share, by Business Segment, 2021
Figure 46: Baxter International: Revenue Share, by Region/Country, 2021
Figure 47: Bioventus: Net Revenue, 2018-2020
Figure 48: Bioventus: Revenue Share, by Business Segment, 2020
Figure 49: Bioventus: Revenue Share, by Region/Country, 2020
Figure 50: Conmed Corp.: Net Revenue, 2017-2021
Figure 51: Conmed Corp.: Revenue Share, by Business Segment, 2020
Figure 52: Conmed Corp.: Revenue Share, by Region/Country, 2021
Figure 53: Johnson & Johnson (DePuy Synthes Companies): Net Revenue, 2017-2021
Figure 54: Johnson & Johnson (DePuy Synthes): Revenue Share, by Business Segment, 2021
Figure 55: Johnson & Johnson (DePuy Synthes Companies): Revenue Share, by Region, 2021
Figure 56: Medtronic PLC: Net Revenue, 2017-2021
Figure 57: Medtronic PLC: Revenue Share, by Business Segment, 2021
Figure 58: Medtronic PLC: Revenue Share, by Region, 2021
Figure 59: Seikagaku Corp.: Net Revenue, 2016-2020
Figure 60: Seikagaku Corp.: Revenue Share, by Business Segment, 2020
Figure 61: Smith & Nephew: Net Revenue, 2017-2021
Figure 62: Smith & Nephew: Revenue Share, by Business Segment, 2021
Figure 63: Smith & Nephew: Revenue Share, by Region, 2021
Figure 64: Stryker Corp.: Net Revenue, 2017-2021
Figure 65: Stryker Corp.: Revenue Share, by Business Segment, 2021
Figure 66: Stryker Corp.: Revenue Share, by Region/Country, 2021
Figure 67: Zimmer Biomet Holdings: Net Revenue, 2016-2020
Figure 68: Zimmer Biomet Holdings: Revenue Share, by Business Segment, 2020
Figure 69: Zimmer Biomet Holdings: Revenue Share, by Region, 2020

Executive Summary

The rapid growth rate of the tissue engineering segment is attributed to rising adoption of products that are designed and developed for the treatment of tissues such as bone, skeletal muscle, cartilage, blood vessel, nervetissue, skin and for complete organs.

Reasons for Doing This Study:


The purpose of this report is to provide a summary of regenerative medicine products for the treatment of diseases and disorders of the bones and joints. Regenerative therapies have the potential to progress medical outcomes, improve quality of life and decrease overall healthcare costs. A major objective is the utilization of living cells to repair or replace body tissue damaged by injury, disorder or the ageing process. The most successful products draw upon multidisciplinary fields such as biology, medicine, engineering and, particularly, biomedical engineering. This report is designed to be a critical decision-making tool for the intended audience, which includes biopharmaceutical market players, potential market entrants and other professionals involved with or interested in cell and gene therapy and regenerative therapy in orthopedic sector.

Companies Mentioned

  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • Baxter International Inc.
  • Bioventus
  • Conmed Corp.
  • Depuy Synthes Products Inc. (Part of Johnson & Johnson)
  • Medtronic plc
  • Seikagaku Corp.
  • Smith & Nephew plc
  • Stryker Corp.
  • Zimmer Biomet Holdings Inc.